BJL
LRMR icon

Brighton Jones LLC’s Larimar Therapeutics LRMR Stock Holding History

Brighton Jones LLC’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.4K Buy
+18,476
New +$73.4K ﹤0.01% 1361

Other funds holding LRMR

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brighton Jones LLC's LRMR Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 18,476 shares worth $56.4K. The stake represents ﹤0.01% of the portfolio and ranks #1361 among its holdings.

64 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Brighton Jones LLC held 18,476 shares of Larimar Therapeutics worth $56.4K as of Q2 2026.
  • Larimar Therapeutics was a new Brighton Jones LLC position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1361 holding.
  • 64 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.